More on WGS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $84.81 |
|
|||
| Open | $84.81 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $84.81 | ||||
| Day Low | $84.81 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 550 | ||||
- Study finds rapid genome sequencing boosts pediatric diagnoses at Seattle Children's
- GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
- Form SCHEDULE 13G GeneDx Holdings Corp. Filed by: GOLDMAN SACHS GROUP INC
- GeneDx launches online exome testing access for pediatric patients
- GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
- Form SCHEDULE 13G/A GeneDx Holdings Corp. Filed by: ARK Investment Management LLC
- GeneDx to Participate in Upcoming Investor Conferences
- GeneDx (WGS) PT Raised to $90 at Canaccord
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- GeneDx Holdings (WGS) Misses Q2 EPS by 14c, Offers Guidance
Entities mentioned with WGS
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
